Astria Therapeutics, Inc. — Investor Relations & Filings
Astria Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for allergic and immunologic diseases. The company's mission is to provide life-changing treatments to patients and their families. Its lead product candidate, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein being developed as a potential long-acting, preventative treatment for Hereditary Angioedema (HAE). The company has reported positive initial proof-of-concept results from its ALPHA-STAR Phase 1b/2 clinical trial for STAR-0215. Astria Therapeutics is guided by patient needs to develop differentiated therapeutics that address significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| OWNERSHIP DOCUMENT | 2025-03-25 | English | |
| 10-K | 2025-03-11 | English | |
| FORM 8-K | 2025-03-11 | English | |
| Major Shareholding Notification 2025 | 2025-02-15 | English | |
| Major Shareholding Notification 2025 | 2025-02-14 | English | |
| Major Shareholding Notification 2025 | 2025-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
9 filings
| |||||
| 12265858 | OWNERSHIP DOCUMENT | 2025-03-25 | English | ||
| 12265859 | 10-K | 2025-03-11 | English | ||
| 12265863 | FORM 8-K | 2025-03-11 | English | ||
| 12265864 | Major Shareholding Notification 2025 | 2025-02-15 | English | ||
| 12265865 | Major Shareholding Notification 2025 | 2025-02-14 | English | ||
| 12265866 | Major Shareholding Notification 2025 | 2025-02-12 | English | ||
| 12265867 | Major Shareholding Notification 2025 | 2025-01-28 | English | ||
| 12265868 | FORM 8-K | 2025-01-13 | English | ||
| 12265869 | Major Shareholding Notification 2025 | 2025-01-07 | English | ||
|
2024
6 filings
| |||||
| 12265871 | FORM 8-K | 2024-12-19 | English | ||
| 12265870 | SC 13G/A | 2024-11-14 | English | ||
| 12265872 | SC 13G/A | 2024-11-14 | English | ||
| 12265873 | SC 13D/A | 2024-11-14 | English | ||
| 12265874 | SC 13G/A | 2024-11-14 | English | ||
| 12265875 | ASTRIA THERAPEUTICS, INC. | 2024-11-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Astria Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33001/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33001 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33001 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33001 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33001}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Astria Therapeutics, Inc. (id: 33001)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.